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Short Communication
Parul V. Purohit
David M. Rocke
Discriminant models for high-throughput
proteomics mass spectrometer data
Center for Image Processing
and Integrated Computing,
University of California,
Davis, USA
We use several different multivariate analysis methods to discriminate between dis-
eased and healthy patients using protein mass spectrometer data provided by Duke
University.lwo problems were presented by the university; one in which the responses
(diseased or healthy) of the patients were not known and second, when the responses
were knowrl. In the latter case, the data can be used as a 'training' set. We attempted
both problems. In particular, we use principle component analysis along with clustering
methods to discriminate for the first problem set and partial least squares coupled with
logistic and discriminant methods when the responses were known. In addition, we
were able to detect regions of interest in the spectrum where there were differences in
the protein patterns between healthy and diseased patients. There was considerable
effort involved in the preprocessing of the data. We used a binning approach to reduce
the number of variables rather than peak heights or peak areas. We performed a
square root transformation on the data to help stabilize the variance; this in turn made
a significant improvement in clustering results.
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Mass spectrometry of proteins promises to be a very
valuable tool in diagnostic applications. There i3re several
challenges to the use of such proteomics data in classifi-
cation and clustering of samples from diseased and nor-
mal patients. In particular, the number of measurements
taken per sample is very large and even if (;ondensed
into peak areas or peak heights, the number of potential
predictors greatly exceeds the number of samples in al-
most all cases. Registration of peaks is difficult. Although
the stated accuracy of the m/z numbers is within 0.1 %,
this can encompass a large range of molecular weights
on an absolute scale. The variance of the measurements
is not constant, with larger peaks having a larger variance.
We propose to tackle the above stated challenges in
order to perform patient discrimination and pinpoint
certain regions of the spectra that may be 01: interest in
determining the discrimination. As mentioned above, two
problems were posted by Duke University. The first data
set was unsupervised, where the responses of the
patients were unknown. For the second data set which
was supervised, the responses of the patients were
known. The data in both the data sets were the same but
the approaches for the two problems remain different.
Both the data sets were given in the raw and processed
formats (only the m/z and corresponding intensities of
the peaks). We worked with the raw form of the data
which allowed us to have the same values for the m/z's
for all the patients. There were a total of 41 patients with
scans per patient conducted over 20 different fractions.
The analysis for either the unsupervised or supervised
problem involves a two-pronged approach. First, the
data have to be preprocessed with the proper back-
ground subtracted, normalized and the different fractions
combined to obtain one integrated spectrum for each
patient. The integrated spectrum is then binned and the
data for all patients formatted in a (n x p) matrix format
with n representing the number of patients (41) and p the
number of variables (discrete m/z's corresponding to the
mean of the m/z of each bin). The range of m/z in all
the raw spectra was restricted only to the region where
the processed files indicated peaks which reduced the
number of raw data points to -53000+ from the original
65000+ for each spectrum. Since the raw m/z interval
values for the spectrum increased as a function of m/z,
we chose bins by a fixed number of m/z points (100 for
the analysis presented here) rather than using a fixed m/z
interval. This allowed for a binned spectrum that was
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normal. We conduct data transformation of the spectra
prior to statistical analysis in order to stabilize the var-
iance of the data. Ideally, a variable transformation of the
type used by Durbin et a/. [1] would be well suited. How-
ever, the lack of replicates in this study precluded us from
using this transformation since the parameter cannot be
estimated. For this study, we performed a simple log
transformation and a square root (Sqrt.) transformation.
A constant value dependent on the transformation was
added to the entire data set to assure that all the intensi-
ties were above 1.0 and 0.0 for the respective transforma-
tions so that the transformed values remain above zero.
Success of the transformations was measured by per-
forming partial least squares (PLS) regression analysis
coupled with logistic and discriminant analysis on the
supervised data set. The Sqrt. transformation seemed to
be the most suitable for these data sets (Table 1). Figure 3
shows the Sqrt. transformed fraction integrated data set
for Patient 1.
more in character with the original data as seen in
Figs. 1-2 for Patient 1. The number of variables, after the
binning process drops to 531 for each raw s,pectrum.
Background for each individual spectrum was estimated
from the region of the spectrum with no peaks (m/z of
170000 and higher). A flat background was used which
was expected to suffice given the multivariate ;approach
to the problems. Each fraction of the spectrum was nor-
malized to an integrated intensity of 1.0 to assure that
each spectrum has the same quantity of analyte and that
the sum of all the fractions would give a true and accurate
spectrum for the patient. There was no normalization con-
ducted between patients to preserve the biological inten-
sity relevance between patients.
The second prong of our approach constitutes multivari-
ate statistics (using SAS). Many of these methods are
based on the assumptions that the data are mlJltivariate
The preprocessing of the data as mentioned above
renders the data in a 41 x 531 matrix that is in the right
format for multivariate statistical analysis. Even after the
binning that reduced the number of variables significantly,
the number of variables remains significantly higher than
the number of observations (patients). For the unsuper-
vised data set, we perform further dimension reduction
by principal component analysis (PCA) selecting the num-
ber of factors or principal components by using an eigen-
value plot and observing the 'jog' in the plot [2, 3]. Four
factors that accounted for 65% of the variance were
used for dimension reduction and further analysis. Eigen-
values and eigenvectors generated from PCA were ob-
tained using a covariance matrix rather than the correla-
tion matrix. This choice associates the large variances
with the large eigenvalues and vice versa as is usually the
1.01.00
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Table 1. Number of patients correctly identifiel:;l by combinations of PLS and PCR regression and
discriminant methods using various transformations. The second number is the success
rate as a percentage. The last row indicates specific patients that were not correctly identi-
fied for the Sqrt. transformation. All discriminations were conducted using leave one out
cross-validation
PLS/LOG I;)LS/DIS PCR/LOG PCR/DIS
No transformation
Log. transformation
Sqrt. transformation
37/90.2%
37/90.2%
41/100%
:39/95.1 %
:39/95.1 %
.!!1/100%
28/68.3%
28/68.3%
30/75.6%
28/68.3%
28/68.3%
32n8%
Sqrt. transformation NA I\JA 4,6,9,15,23,27,4,10,31,35,36,
33,36,39,40 38,39,40,41
a correct discrimination of 28 patients (68%) using the
flexible-beta hierarchical method [3]. Using this result as
a seed for the k-means method did not improve discrimi-
nation. Figure 5 shows the results of the clustering where
the symbols indicate the expected responses. It is inter-
esting to note that Cluster 1 has only diseased patients
whereas Cluster 2 contains all the healthy patients and
some of the patients categorized as diseased. It is possi-
ble that the diseased patients in this latter cluster may
have a different form or different stage of the disease. Fur-
ther analysis using PLS also suggests this scenario.
For the supervised data set, we reduced dimensions
using PLS and then perform logistic (LOG) and dis-
criminant analysis (DIS) for discrimination. We compare
these results using principal components regression and
case in spectral data. Figure 4 shows a scores plot of
Principal Component 1 vs. Principal Component 2 that
shows the relationships between the patients with
respect to each other. Different symbols have been used
to indicate the expected responses (obtained from the
supervised data) between the sick and healthy; however,
this information was not used for the analysis. It is very
clear that the patients do not cluster neatly into two
groups indicating that results using cluster analysis would
be tenuous. There is an outlier (Patient 15) which we
removed from the data set to enhance our ch;:lnces for
better discrimination.
Hierarchical cluster analysis was performeci on the
reduced data matrix using a two-cluster optiorl. Several
standard clustering methods were attempted and we
obtained the best separation of the two true groups for
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Figure 5. Graphic demonstrating the results of cluster
analysis performed on PCA reduced data matrix. The
black dots refer to the patients that are expected to be
diseased, gray dots to the ones that are expected to be
healthy.
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Figure 7. Region of the integrated spectra for six patients
(Patients 1, 3, 7, 12, 25 and 27) for bin 118. This bin lies
at the extremity in the weights plot as shown in Fig. 6.
responding bin numbers lying at the extremities of the
plot have been labeled along with one bin (Bin 432) that
lies fairly close to the center. We expect to find significant
differences in the signal of the spectra for the bins lying at
the extremities. Figure 7 shows the differences in the raw
integrated spectra of six patients for the bin region 118.
The patients chosen are Patients 1, 3, 7, 12, 25 and 27
based on their expected responses and the responses
as indicated by cluster analysis shown in Fig. 5. Patients
1 and 12 are diseased but have been categorized as
healthy in the cluster plot whereas patients 3 and 7 are
diseased and categorized as such in the figure. Patients
25 and 27 are healthy and categorized as such in Fig. 5. It
can be clearly seen in Fig. 7 that for patients 3 and 7, there
is a prominent peak at m/z = -12900 which is faintly
recognized for patient 1 and patient 12 and not at all for
patients 25 and 27. This may be a diagnostic peak and is
consistent with the results of the cluster analysis. Patients
3 and 7 have an advanced stage of the disease as indi-
cated by the peak and the results shown in Fig. 5,
whereas patients 1 and 12 may have an onset of the dis-
ease that has not progressed to latter stages. Patients 25
and 27 do not have the diseased as categorized by the
absence of the peak in Fig. 7 and through cluster analysis
as shown in Fig. 5. The six patients picked may not be
entirely representative, but Fig. 4 indicates that distin-
guishing between healthy and diseased patients remains
a difficult task through cluster analysis and different clus-
tering techniques may yield slightly different results from
those shown in Fig. 5. However, one can still attach some
significance to the peak shown in Fig. 7 that illustrates a
peak (or protein) that seems to be a marker of disease.
Figure 8 illustrates the lack of any significant difference in
spectral patterns in the bin region 432 which is located
fairly centrally in the weights plot of Fig. 6. Bins 3-8 which
then discrimination using LOG and DIS [4-7]. All analysis
was conducted using a leave one out cross-validation
approach using the rest of the matrix to predict the
response of the patient of interest. The number of factors
retained was chosen by conducting split-sample valida-
tion PLS and calculating the minimum root mean of the
predicted residual sum of squares. The correctly identi-
fied discriminations achieved using these methods are
tabulated in summary form in Table 1 for the various trans-
formations. The last row in the table gives the numbers
of the specific patients that were not correctly identified
for the Sqrt. transformation. In general, the ~)rediction
rates achieved using PLS are higher than that using
principal component regression [7]. We have sel3n similar
results for other problems with discrimination issues using
these methods. Thus prediction for a new patient would
be greatly enhanced if a training set with knoVw'n patient
conditions is used. This training set can be used to calcu-
late PLS factors and subsequently applied to the new
patient for prediction calculations.
The weights plot obtained from the PLS analysis provides
a powerful tool to recognize the bins that are rE~levant in
terms of the differences between the healthy and dis-
eased patients. The weight factors can be considered to
be the eigenvectors of the matrix XTyyTX where! X repre-
sents the data matrix associated with the variables and Y
the column matrix associated with the responsE~s. A plot
of Weight Factor 1 vs. Weight Factor 2 that demonstrates
the maximum variance in the predictor-response combi-
nation is shown in Fig. 6. Those bins with large vieights in
absolute value (ones lying at the extremities of the plot)
are more important in predicting the variations than the
ones lying close to the origin. Several bins with their cor-
-0.21 , ,-
-.t) -.05 0.00 0.05 0.10
Weight Factor 1
Figure 6. A weights factor plot obtained from PI_S analy-
sis of the binned data matrix. A few of the bins; lying on
the extremities and a bin lying near the origin h,ave been
marked and discussed in the text.
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ular, for discrimination studies, for an unsupervised data
set, a combination of PCA and cluster analysis along with
appropriate preprocessing of the data, can lead to mean-
ingful and promising results. Better discrimination can
however be achieved if one has a credible training data
set that can be used for future predictions as can be
seen with our analysis on supervised data using PLS and
discrimination methods. We are expecting even further
improvements on our discrimination abilities if many of
the preprocessing and data steps can be optimized. We
have demonstrated that the weights plot obtained by
using PLS can be a powerful tool in obtaining diagnostic
protein profiles in diseased patients.
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Figure 8. Region of the integrated spectra for si;( patients
(Patients 1, 3, 7, 12, 25 and 27) for bin 432. This bin lies
fairly closeness to the origin in the weights plot ;~s shown
in Fig. 6.
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also lie at the extremities of the plot were not considered
for meaningful comparison due to their low ~n/z value
and closeness to large fluctuations in the intensity. Study
of 'relevant' bins in this fashion may be a key in I:letecting
the minor spectra changes expected between healthy
and diseased patients.
Summarizing our results, we have shown that mlJltivariate
analysis is a powerful tool in analyzing high-throughput
mass spectrometer data for proteomics studies. In partic-
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